Researchers led by a team at Canada’s Centre for Addiction and Mental Health (CAMH) have focused their work on a small molecule drug that targets the glutamate receptor AMPA, and results from the study show great promise in its new approach to treating MS.
https://newatlas.com/medical/ms-drug-re ... G-eHMuInJY
One more candidate for nerve repair
-
- Similar Topics
- Replies
- Views
- Last post
-
- 40 Replies
- 7104 Views
-
Last post by ElliotB
-
- 0 Replies
- 1137 Views
-
Last post by frodo
-
- 3 Replies
- 2306 Views
-
Last post by tzootsi
-
- 2 Replies
- 1153 Views
-
Last post by frodo
-
- 0 Replies
- 1911 Views
-
Last post by Anonymoose
-
- 2 Replies
- 1637 Views
-
Last post by jimmylegs
-
- 0 Replies
- 686 Views
-
Last post by DIM
-
- 1 Replies
- 1335 Views
-
Last post by Jaded
-
- 6 Replies
- 1777 Views
-
Last post by NHE